Eighty years ago, during a time of national devastation and widespread epidemics, medical professionals confronted extraordinary challenges. Amid scarce resources and the thunder of artillery, they extracted bacterial strains from makeshift cultures and even leather shoes. With their bare hands and unwavering determination, they pioneered China’s biopharmaceutical path.

Eighty years later, the makeshift workshops of the past have transformed into a modern biopharmaceutical powerhouse. With fully automated production lines, cutting-edge gene engineering, and innovative adjuvant technologies, China National Pharmaceutical Group Co., Ltd. (Sinopharm) safeguards public health. Billions of vaccine doses now reach every corner of the globe, reinforcing the shared future of humanity. From the struggle for survival during wartime to the era of peace and prosperity, China’s biopharmaceutical industry has made a historic leap.